Table 1. Demographic and clinical characteristics of the patient participants (n = 111).

Patient characteristic	n (%)
Gender
Male	37 (33.3%)
Female	74 (66.7%)
Male/female ratio	0.5/1
Age (years)
Median (range)	61 (23–85)
Highest level of education
Less that high school	6 (5.4%)
High school or college education	47 (42.3%)
University education with bachelor's or master's degree	53 (47.7%)
University education with doctoral degree	5 (4.5%)
ECOG performance status
0	25 (22.5%)
1	27 (24.3%)
2	38 (34.2%)
>2	21 (19.0%)
Type of treatment
Chemotherapy	97 (87.4%)
Targeted therapy	17 (15.3%)
Immunotherapy	12 (10.8%)
Hormonotherapy	1 (0.9%)
Bisphosphonates	1 (0.9%)
Transfusion	2 (1.8%)
Treatment setting
Neoadjuvant	3 (2.7%)
Adjuvant	42 (37.8%)
First-line metastatic	35 (31.5%)
Second-line metastatic	6 (5.4%)
Third-line metastatic	6 (5.4%)
Hematologic malignancy	19 (17.1%)
Purpose of treatment
Curative	60 (54.0%)
Palliative	51 (46.0%)
Life expectancy
<1 year (but >1 month)	24 (21.6%)
>1 year	87 (78.4%)

ECOG: Eastern Cooperative Oncology Group.